Pioneering the Lab of
the Future, Today

Dr. Amrik Mahal, recently awarded the British Empire Medal, has 25+ years’ experience working in the pharmaceutical sector, primarily in Research & Development. Having worked for AstraZeneca, Glaxo Wellcome, and Evotec, he is currently the Global Head of IT for Research at AstraZeneca, accountable for developing and driving the IT strategy, partnering with the R&D senior leaders and delivery of projects and services to discovery and development scientists. Amrik is covering a wide range of scientific applications and end user disciplines. He has a proven ability to successfully provide leadership of teams across multiple domains, internally and externally with academia and industry. Amrik will share the AstraZeneca Digitization Journey and the current and potential future role of Sapio.

As AWS Head of AI and Modern Data Strategy, Ben Schreiner is a trusted advisor helping customers unlock transformative growth. With 25+ years of global experience spanning enterprise technology, startups, and highly regulated industries such as financial services, Ben provides a unique perspective on driving innovation through emerging technologies like generative AI.

Joanne currently is responsible for creating a portfolio of external investments and strategic alliances that advance technology and product strategies and contribute to the attainment of research, development, and commercialization goals. She is a recognized thought leader in precision medicine with a track record of translating academic research into medical and commercial returns. Joanne has extensive experience as an entrepreneur, scientist, and strategist executing and managing complex medical and healthcare business transactions.

As a Principal Scientist II in Biologics Discovery at Johnson & Johnson Innovative Medicine, Sidharth Mohan is responsible for developing high-throughput analytics and purification workflows. His work includes designing informatics-driven solutions and automation processes to enhance efficiency in biologics discovery and development. Previously, he was a key member of the analytical team at Avitide Inc. (now part of Repligen), where he contributed to the development of custom affinity purification solutions using high-throughput technologies. His expertise lies in integrating advanced technologies with innovative scientific approaches to drive transformative advancements in biologics research, ultimately aiming to improve global patient outcomes.

Monica Lopez is a Process Development Team Lead at Oxford Biomedica, bringing over 10 years of experience in the antibody and viral vector fields. She is passionate about digital transformation in the biopharma industry and enjoys discovering and implementing new software platforms that enhance efficiency and improve data management. Oxford Biomedica is a quality and innovation-driven CDMO with over 25 years of experience. They offer extensive end-to-end capabilities in lentivirus, AAV vectors, and adenovirus systems. Notably, they were the first worldwide to administer lentiviral vector gene therapy in vivo, the first commercial supplier of lentiviral vectors for CAR-T therapy, and a large-scale manufacturer of the COVID-19 vaccine.

Over the years Shane has built a strong foundation in molecular biology and psychology. Shane excels in digital transformation within the life sciences, focusing on solutions that enhance both user experience and operational efficiency. Shane has been instrumental in supporting Sapio to truly understand the Olink processes resulting in the recently established Sapio-Olink partnership. Shane is driven by a passion for fostering collaboration across teams and departments and has dedicated his career to implementing digital initiatives that streamline processes and improve business outcomes. Currently, as the IT Business Solution Lead at Olink, he leads IT projects, including a complex, multi-site, multi-regional enterprise LIMS implementation. Previously, in the role of LIMS System Engineer, he led a comprehensive pre-study to gather user requirements, optimize processes, evaluate LIMS vendors, and establish governance frameworks for agile project management.

Nicolas leads the team providing Digital and Data services for R&D at CureVac, and is focused on unlocking value through process simplification and digitization. We enable a seamless and frictionless end-to-end approach for the collection, integration, and analysis of scientific data, using a combination of inhouse software/data engineering and commercial software packages. With a strong interest to be at the forefront of digital transformation and cutting-edge innovation, he combines a scientific background with more than 20 years’ experience in different advisory and delivery roles for various domains in the health & life sciences space.

Loganathan Kumarasamy heads the regulatory compliance and scientific informatics solutions at Zifo Technologies Inc. He has a masters in Regulatory Affairs for Medical devices from Northeastern University, Boston and possess RAPS – RAC (US) Certification since 2018. He has over 12 years of experience in providing pragmatic solutions in life sciences and medical device industry focused on regulatory compliance, quality assurance and scientific informatics.

Josh Kramer brings 25 years experience leading enterprise digital transformation, working with fast growing national commercial independent diagnostic laboratories since 2012. As the Managing Partner at Leap Consulting Group, Josh and his team support laboratories digital front doors, preanalytical, LIMS, lab automation, bioinformatics cloud, report writing, RCM, extensive data analytics, and Pharma RWD collaboration transformations across the laboratory industry. Josh and his team at Leap also provide more traditional IT advisory, journey to the cloud, ERP transformation, and other mainstream digital consulting services to CLIA, CAP, FDA, and GXP focused laboratories throughout the United States. Josh has been recognized by ONC, ACHE, NJBIZ, Forbes, and EY for his strategic vision, innovative thinking, and practical ability to drive innovation and positive change through developing technology teams and assets across industries. Josh and his team have partnered with Sapio since 2014 and continue to design, implement, and drive change utilizing Sapio LIMS and ELN platform as a key tool in their offering.

en has 20+ years of experience in Laboratory Informatics. Prior to his focus on software, he worked in a research lab as an organic chemist at Pfizer. His software experience includes customer focused roles at IntelliChem, Symyx, Accelrys, and Dassault Systemes prior to joining Astrix. He brings a wealth of technical and program management experience to his role leading lab informatics implementations at life science companies. He is well-versed in the latest technologies, strategies, and approaches for digital transformation. Ken is able to help clients realize the full potential of their technology investments and achieve their business goals.

Kevin Cramer serves as the founder and CEO of Sapio Sciences, leveraging a wealth of tech expertise to lead product design and development within the company. His dynamic career includes strategic roles at tech and life sciences companies such as Siebel Systems, Sybase, Biomind, and Veloxity, with a unique skill set that blends technical acumen and sales prowess. A well-established authority in the lab informatics field, Kevin’s professional footprint extends to his contributions to various papers in Nature Genetics, where he applied statistical and machine learning methodologies to the interpretation of genetic data. His educational background includes a Bachelor’s Degree in Information Systems from York College, PA. At the helm of Sapio Sciences, Kevin is driven by his dedication to accelerating the drug R&D process. His vision encompasses a unified platform designed to streamline the creation of large and small molecules, assess their efficacy, manage data capture at scale, and harness the power of data visualization. The platform also incorporates advanced analytical and AI strategies to augment the discovery process.

Gordon McCall is an accomplished Chief Financial Officer (CFO) known for his ability to drive financial success and foster business growth. With a strong finance and accounting background, Gordon’s extensive experience positions him as a valuable asset in his role. Having served as CFO for multiple organizations, Gordon has consistently scaled businesses and delivered exceptional results. His passion for supporting private equity-backed companies has honed his expertise in financial management, forecasting, fundraising, and mergers and acquisitions.

Rob Brown is Senior Director of Product Marketing and Presales at Sapio Sciences. He was previously at Dotmatics where he was Head of Global Presales, Product Marketing & Product Management. Earlier in his career he ran product marketing teams at Accelrys, SciTegic and MSI. Rob started his career as a postdoc and later research scientist at Abbott Laboratories (now Abbvie). He received his PhD in Cheminformatics from the University of Sheffield, UK.